ceftriaxone + cefazolin

Ceftriaxone + cefazolin is a combination of two first- and third-generation cephalosporin antibiotics, both belonging to the beta-lactam class. This combination is not a standard fixed-dose product but may be used off-label in clinical practice for severe or complicated bacterial infections when broader coverage or synergistic effects are desired. Both drugs act by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to bactericidal activity against susceptible organisms. Ceftriaxone has broad-spectrum activity, including many gram-negative and some gram-positive bacteria, while cefazolin primarily targets gram-positive cocci and some gram-negative organisms. The combination may be considered in certain clinical scenarios where dual beta-lactam therapy is warranted, though this use is uncommon compared to other combinations.